QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
NASDAQ:ATRA

Atara Biotherapeutics SEC Filings & 10K Form

$19.56
+0.24 (+1.24 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.42
Now: $19.56
$20.30
50-Day Range
$18.27
MA: $20.79
$25.82
52-Week Range
$4.52
Now: $19.56
$28.20
Volume817,309 shs
Average Volume899,107 shs
Market Capitalization$1.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.65

SEC Filings

Atara Biotherapeutics (NASDAQ:ATRA) SEC Filings

DateFilerForm TypeView
01/19/2021
3:02 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:31 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
10:43 AM
Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
12/18/2020
5:35 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:32 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4/A
12/09/2020
4:08 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
4:07 PM
Atara Biotherapeutics (Filer)
Form 424B5
12/07/2020
3:28 PM
Atara Biotherapeutics (Filer)
Form 424B5
12/07/2020
7:26 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2020
3:08 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:07 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:07 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
3:19 PM
Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:41 PM
Atara Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2020
3:11 PM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2020
6:39 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
6:38 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
6:37 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:18 PM
Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
8:15 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:46 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:46 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:45 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:44 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:43 PM
Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
4:27 PM
Atara Biotherapeutics (Filer)
Form 424B5
05/20/2020
5:11 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:11 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:10 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:17 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:16 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2020
6:44 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
6:43 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2020
4:25 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2020
3:17 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:16 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/07/2020
3:21 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
7:46 AM
Atara Biotherapeutics (Filer)
Form 424B5
02/27/2020
6:47 AM
Atara Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
6:35 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
7:53 PM
Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:50 PM
Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/10/2020
6:48 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:47 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
10:26 AM
Atara Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/28/2020
3:31 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
6:51 AM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:40 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
3:12 PM
Atara Biotherapeutics (Subject)
BRIDGER MANAGEMENT, LLC (Filed by)
Form SC 13G
10/25/2019
4:16 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
3:25 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
9:20 AM
Atara Biotherapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/08/2019
6:51 AM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:40 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
1:27 PM
Atara Biotherapeutics (Subject)
Camber Capital Management LP (Filed by)
Form SC 13G
07/22/2019
4:15 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:25 PM
Atara Biotherapeutics (Filer)
Form 424B5
07/18/2019
3:07 PM
Atara Biotherapeutics (Filer)
Form 424B5
07/01/2019
4:58 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:01 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:00 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:00 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:59 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:58 PM
Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
3:20 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:19 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2019
5:04 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:16 PM
Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
4:00 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
7:25 AM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
7:10 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:32 PM
Atara Biotherapeutics (Issuer)
Berger Dietmar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
3:31 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:35 PM
Atara Biotherapeutics (Filer)
Form DEFA14A
04/29/2019
4:36 PM
Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:19 PM
Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
3:33 PM
Atara Biotherapeutics (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
6:22 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:16 PM
Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:16 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4/A
03/27/2019
4:19 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:18 PM
Atara Biotherapeutics (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:18 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:17 PM
Atara Biotherapeutics (Issuer)
Berger Dietmar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:17 PM
Atara Biotherapeutics (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
3:19 PM
Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
11:59 AM
Atara Biotherapeutics (Filer)
Form CT ORDER
03/05/2019
5:58 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:09 PM
Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:08 PM
Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
Form 4/A
02/26/2019
7:55 AM
Atara Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2019
7:52 AM
Atara Biotherapeutics (Filer)
Form 424B5
02/26/2019
7:47 AM
Atara Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
6:41 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
9:14 AM
Atara Biotherapeutics (Subject)
Camber Capital Management LP (Filed by)
Form SC 13G/A
02/14/2019
6:53 AM
ArrowMark Colorado Holdings LLC (Filed by)
Atara Biotherapeutics (Subject)
Form SC 13G/A
02/12/2019
6:18 PM
Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.